[
  {
    "ts": "2025-12-10T02:49:24+00:00",
    "headline": "CVS shares jump on raised profit outlook for 2025",
    "summary": "<body><p>STORY: EDITOR'S NOTE:THIS STORY WAS REFILED TO CORRECT A LINE SAYING THE COMPANY'S PROFIT FORECAST TOPPED ESTIMATES</p><p>Shares of CVS rose as much as five percent Tuesday morning after the company raised its 2025 profit outlook for the fourth time.</p><p>CEO David Joyner said at the company’s investor day that CVS has delivered on its promises this year and will now focus on improving consumer experiences across the business.</p><p>He added, \"We've invested heavily in what I would believe is the challenge in the marketplace, which is a lack of trust.\"</p><p>The upbeat outlook caps a year in which Joyner pushed through a sweeping overhaul, which involved cutting costs, exiting underperforming markets, and strengthening management to revive investor confidence.</p><p>CVS shares have responded with gains of more than 70% this year.</p><p>CVS said in May that it plans to exit the market for Obamacare health insurance plans in 2026, as rising medical costs have pressured health insurers in recent quarters.</p><p>The company expects its Aetna insurance business and CVS Caremark pharmacy benefit management unit to drive growth, as their profit margins are expected to return to target levels.</p><p>Analysts at Leerink Partners said in a note that, \"CVS' near-term momentum should set the stage for what remains a robust growth recovery story.”</p></body>",
    "url": "https://finance.yahoo.com/video/cvs-forecasts-profit-above-estimates-190643152.html",
    "source": "Reuters Videos",
    "provider": "yfinance",
    "raw": {
      "id": "c4cbda95-40b1-3ef5-b5b2-6e4cd16ae945",
      "content": {
        "id": "c4cbda95-40b1-3ef5-b5b2-6e4cd16ae945",
        "contentType": "VIDEO",
        "title": "CVS shares jump on raised profit outlook for 2025",
        "description": "<title><body><p>STORY: EDITOR'S NOTE:THIS STORY WAS REFILED TO CORRECT A LINE SAYING THE COMPANY'S PROFIT FORECAST TOPPED ESTIMATES</p><p>Shares of CVS rose as much as five percent Tuesday morning after the company raised its 2025 profit outlook for the fourth time.</p><p>CEO David Joyner said at the company’s investor day that CVS has delivered on its promises this year and will now focus on improving consumer experiences across the business.</p><p>He added, \"We've invested heavily in what I would believe is the challenge in the marketplace, which is a lack of trust.\"</p><p>The upbeat outlook caps a year in which Joyner pushed through a sweeping overhaul, which involved cutting costs, exiting underperforming markets, and strengthening management to revive investor confidence.</p><p>CVS shares have responded with gains of more than 70% this year.</p><p>CVS said in May that it plans to exit the market for Obamacare health insurance plans in 2026, as rising medical costs have pressured health insurers in recent quarters.</p><p>The company expects its Aetna insurance business and CVS Caremark pharmacy benefit management unit to drive growth, as their profit margins are expected to return to target levels.</p><p>Analysts at Leerink Partners said in a note that, \"CVS' near-term momentum should set the stage for what remains a robust growth recovery story.”</p></body></title>",
        "summary": "<body><p>STORY: EDITOR'S NOTE:THIS STORY WAS REFILED TO CORRECT A LINE SAYING THE COMPANY'S PROFIT FORECAST TOPPED ESTIMATES</p><p>Shares of CVS rose as much as five percent Tuesday morning after the company raised its 2025 profit outlook for the fourth time.</p><p>CEO David Joyner said at the company’s investor day that CVS has delivered on its promises this year and will now focus on improving consumer experiences across the business.</p><p>He added, \"We've invested heavily in what I would believe is the challenge in the marketplace, which is a lack of trust.\"</p><p>The upbeat outlook caps a year in which Joyner pushed through a sweeping overhaul, which involved cutting costs, exiting underperforming markets, and strengthening management to revive investor confidence.</p><p>CVS shares have responded with gains of more than 70% this year.</p><p>CVS said in May that it plans to exit the market for Obamacare health insurance plans in 2026, as rising medical costs have pressured health insurers in recent quarters.</p><p>The company expects its Aetna insurance business and CVS Caremark pharmacy benefit management unit to drive growth, as their profit margins are expected to return to target levels.</p><p>Analysts at Leerink Partners said in a note that, \"CVS' near-term momentum should set the stage for what remains a robust growth recovery story.”</p></body>",
        "pubDate": "2025-12-10T02:49:24Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/uu/api/res/1.2/YcYYkIHbIlV2CEK_Cnbp8w--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/ac25f160-9929-48f6-b1f4-59f9214d18dd/main/1280x720/39s450ms/match/image.jpg",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8fTbqhNSnBBGV.YatXE6hg--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/ac25f160-9929-48f6-b1f4-59f9214d18dd/main/1280x720/39s450ms/match/image.jpg.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eS_CGBwQqn_2gh_6Sn0dAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/ac25f160-9929-48f6-b1f4-59f9214d18dd/main/1280x720/39s450ms/match/image.jpg.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters Videos",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/cvs-forecasts-profit-above-estimates-190643152.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/cvs-forecasts-profit-above-estimates-190643152.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T09:12:24+00:00",
    "headline": "How Recent Shifts Are Rewriting the Story for CVS Health",
    "summary": "CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 per share as analysts factor in modestly stronger long term revenue growth assumptions. While the discount rate has ticked up from around 7.18% to about 7.35%, reflecting a marginally higher required return amid lingering industry risks, updated research still leans constructive given improving earnings visibility and expectations for medium term margin recovery. Stay...",
    "url": "https://finance.yahoo.com/news/recent-shifts-rewriting-story-cvs-091224792.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "396776c2-216e-3a11-bfe6-82765f5b6f33",
      "content": {
        "id": "396776c2-216e-3a11-bfe6-82765f5b6f33",
        "contentType": "STORY",
        "title": "How Recent Shifts Are Rewriting the Story for CVS Health",
        "description": "",
        "summary": "CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 per share as analysts factor in modestly stronger long term revenue growth assumptions. While the discount rate has ticked up from around 7.18% to about 7.35%, reflecting a marginally higher required return amid lingering industry risks, updated research still leans constructive given improving earnings visibility and expectations for medium term margin recovery. Stay...",
        "pubDate": "2025-12-10T09:12:24Z",
        "displayTime": "2025-12-10T09:12:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b281afd73848ff2f053c086d0c5a15e9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/az3maBuei.SURwtIZ4ic4A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b281afd73848ff2f053c086d0c5a15e9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cKBGpv3s0tfaq.7ZzVUgPA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b281afd73848ff2f053c086d0c5a15e9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/recent-shifts-rewriting-story-cvs-091224792.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/recent-shifts-rewriting-story-cvs-091224792.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T04:02:53+00:00",
    "headline": "3 Reasons CVS is Risky and 1 Stock to Buy Instead",
    "summary": "CVS Health’s 22.1% return over the past six months has outpaced the S&P 500 by 8.7%, and its stock price has climbed to $78.44 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
    "url": "https://finance.yahoo.com/news/3-reasons-cvs-risky-1-040253297.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "749494df-1f58-34b0-9ee0-919eaabf64a7",
      "content": {
        "id": "749494df-1f58-34b0-9ee0-919eaabf64a7",
        "contentType": "STORY",
        "title": "3 Reasons CVS is Risky and 1 Stock to Buy Instead",
        "description": "",
        "summary": "CVS Health’s 22.1% return over the past six months has outpaced the S&P 500 by 8.7%, and its stock price has climbed to $78.44 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
        "pubDate": "2025-12-10T04:02:53Z",
        "displayTime": "2025-12-10T04:02:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CVS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TljU2TKBBw.om82sijmNHg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pwdlNJA5IleaBBwQa3TKTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-cvs-risky-1-040253297.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-cvs-risky-1-040253297.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]